Shares in Roche Holding (ROG.S) rose about 2% on Monday, outperforming a largely unchanged European healthcare index, after the Swiss drugmaker announced it is advancing its experimental obesity drug, CT-388, to a late-stage clinical trial.
22 Sep 2025-13:48
22 Sep 2025-13:48
